WHC is still in active development. Read this to understand our approach.
depiction of MFOCDFTXLCYLKU-UHFFFAOYSA-N.svg
tripsit

mephenmetrazine

Verificar en tripsit

isomerdesign

Phendimetrazine

Verificar en isomerdesign

pubchem

Antapentan

Verificar en pubchem

drugmap

Phendimetrazine

Verificar en drugmap

wiki

Phendimetrazine

Verificar en wiki

Data

InChI: InChI=1S/C12H17NO/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3

Sinónimos: Phendimetrazine [INN:BAN], Wehless, (2R-trans)-3,4-Dimethyl-2-phenylmorpholine,NSC 169187,PHENDIMETRAZINE [HSDB],CHEMBL1615439,Phendiet, 3,4-Dimethyl-2-phenylmorpholine, Anorex-SR (TN),Mephenmetrazine,DB01579,ZINC22010387,Fendimetrazina [INN-Spanish], (+)-3,4-Dimethyl-2-phenylmorpholine, Hyrex,Adphen,4-mpm,Adipost,Morpholine, 3,4-dimethyl-2-phenyl-, (2S,3S)-, Morpholine, 3,4-dimethyl-2-phenyl, Phendimetrazine, (2S-trans)-isomer, Phendimetrazine (INN),NSC-169187,C07904, Melfiat (TN), Sedafamen,Ditral,CHEBI:8059, Adipost (TN),AB2794W8KV,UNII-AB2794W8KV, Phendimetrazine [INN:BAN],(2S,3S)-3,4-dimethyl-2-phenyl-morpholine, 3,4-Dimethyl-2-phenyltetrahydro-1,4-oxazine, Appecon (TN),morpholine,3,4-dimethyl-2-phenyl-,trans-,Phendimetrazine (INN),Antapetan,Fendimetrazina,3,4-Dimethyl-2-phenyltetrahydro-1,4-oxazine,Obablan, Prelu-2 (TN),27032-15-1,HSDB 3381,Anorex,PHENDIMETRAZINE [INN],phendimetrazine,EINECS 211-204-6,SCHEMBL598950, Dyrexan,Phendimetrazinum [INN-Latin], Obezine (TN), (+)-Phendimetrazine, Plegine (TN), Adphen (base),(2S,3S)-3,4-Dimethyl-2-phenylmorpholine, Phendimetrazinum, Phendiet (TN),Phendimetrazinum,PHENDIMETRAZINE [VANDF], Bontril PDM (TN), Statobex (TN),Panrexin, Phendimetrazinum [INN-Latin],PHENDIMETRAZINE [MI],Morpholine, 3,4-dimethyl-2-phenyl-, (2S-trans)-, (2S,3S)-3,4-Dimethyl-2-phenylmorpholine, D-2-Phenyl-3,4-dimethylmorpholine,Phendimetrazine, Antapentan,4-methylphenmetrazine, Mephenmetrazine,634-03-7,D08347,(2R-trans)-3,4-Dimethyl-2-phenylmorpholine,PHENDIMETRAZINE [WHO-DD], Fendimetrazina,Bontril,Antapentan, X-Trozine, 3-Phenyl-2-methylmorpholine, Fendimetrazina [INN-Spanish],3,4-Dimethyl-2-phenylmorpholine,Adphen (base),AKOS006281399,DTXSID1023447,Morpholine, 3,4-dimethyl-2-phenyl-, (+)-

Estimated data

Solubilidad: -1.132 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 92.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.